Digital Therapeutics Summit – Digital Therapeutics Summit

Digital Therapeutics represents an opportunity to capitalize on technology and efficiency while delivering an elevated standard of care to patients. The innovation of digital therapeutics will enable the population to monitor and manage their healthcare as well as prevent diseases and improve their patient outcomes. This is a critical time for the industry as guidelines are put in place and best practices are being developed. In order to advance the industry, it is critical for digital therapeutics owners, healthcare providers, payers and pharmaceutical organizations to come together and create mutually beneficial partnerships.

The Digital Therapeutics Strategic Partnerships Summit is designed to be a meeting of the stakeholders, featuring real case-studies and lessons learned, to foster collaboration and ensure a common goal is defined. The goal of this Summit is to provide tangible resources while discussing standards for regulatory pathways, the benefits of strategic partnerships, and the importance of data sharing and governance. The Summit will focus on collaborating, educating and strategizing as an industry.

CONFERENCE CO-CHAIRS

Joel Sangerman,
Chief Commercial Officer,
CLICK THERAPEUTICS

Ruchita Sinha,
Former Senior Director of Investments,
SANOFI VENTURES

FEATURED SPEAKERS


Edward Cox,
CEO,
DTHERA SCIENCES

Debra Reisenthel,
Founding CEO, Freespira Digital Therapeutic,
PALO ALTO HEALTH SCIENCES

Yoshinori Satomi,
Associate Director, Digital Intelligence Dept.,
SHIONOGI

Adam Kaufman,
President and CEO,
CANARY HEALTH

Ryan Sysko,
CEO,
AMALGAMRX

Mark Bini,
Vice President, New Solutions,
EXPRESS SCRIPTS

Mette Dyhrberg,
Founder and CEO,
MYMEE

Kevin McRaith,
CEO and President,
WELLDOC

Vincent Hennemand,
SVP, Strategy, Corporate and Business Development,
AKILI INTERACTIVE

Barbara Eichorst,
Global Diabetes and Digital Therapeutics Clinical Liaison,
VOLUNTIS

Conference Objectives:

Join the speaking faculty as they dive deep and collaborate to detail tactical solutions and their lessons learned in strategic partnerships, commercial models, regulatory pathways and data standards. As innovative companies continue to pave the way in this industry, there are many strategies and topics to be discussed between the above-mentioned stakeholders, including:

  • Market Access
  • The New Commercial Model
  • Regulatory Pathways
  • Scalability Models
  • Partnership Opportunities and Strategies
  • Clinical Validation
  • Data Management and Communication

Who Should Attend

This conference is designed for professionals from digital therapeutics, pharmaceutical, biotech, and medical device companies with responsibilities in the following areas:

  • Digital Therapeutics
  • Digital Health
  • Digital Medicine
  • Digital Strategy
  • Tech Development
  • Commercial Strategy
  • Market Access
  • Commercialization
  • Personalized Healthcare
  • Medical Devices
  • Combination Products
  • Product Development/Management
  • Medical Affairs

This conference is also of interest to:

  • Digital Health Software Developers
  • Data Management Service Providers
  • Technology and Digital Solutions Providers
  • Investment and CV Firms
Startdate: 2019-03-18
End Date 2019-03-19

Description: Analyze Statistics, Data Management, And Operations Through Interim Analysis For More Efficient Clinical Trials
Performer: ExL Events
Address : Digital Therapeutics Summit